Biomimetic polymers in pharmaceutical and biomedical sciences

被引:115
作者
Drotleff, S
Lungwitz, U
Breunig, M
Dennis, A
Blunk, T
Tessmar, J
Göpferich, A
机构
[1] Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany
[2] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA
[3] Rice Univ, Dept Bioengn, Houston, TX 77251 USA
关键词
biomaterial; biomimetic; tissue engineering; cell signaling; surface attachment; gene therapy; drug targeting;
D O I
10.1016/j.ejpb.2004.03.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review describes recent developments in the emerging field of biomimetic polymeric biomaterials, which signal to cells via biologically active entities. The described biological effects are, in contrast to many other known interactions, receptor mediated and therefore very specific for certain cell types. As an introduction into this field, first some biological principles are illustrated such as cell attachment, cytokine signaling and endocytosis, which are some of the mechanisms used to control cells with biomimetic polymers. The next topics are then the basic design rules for the creation of biomimetic materials. Here, the major emphasis is on polymers that are assembled in separate building blocks, meaning that the biologically active entity is attached to the polymer in a separate chemical reaction. In that respect, first individual chemical standard reactions that may be used for this step are briefly reviewed. In the following chapter, the emphasis is on polymer types that have been used for the development of several biomimetic materials. There is, thereby, a delineation made between materials that are processed to devices exceeding cellular dimensions and materials predominantly used for the assembly of nanostructures. Finally, we give a few current examples for applications in which biomimetic polymers have been applied to achieve a better biomaterial performance. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:385 / 407
页数:23
相关论文
共 182 条
  • [1] ALBERTS B, 1994, MOL BIOL CELL, P502
  • [2] ALBERTS B, 1994, MOL BIOL CELL, P769
  • [3] ALBERTS B, 1994, MOL BIOL CELL, P618
  • [4] ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
  • [5] Barany G., 1980, PEPTIDES, P1
  • [6] STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM
    BAZILE, D
    PRUDHOMME, C
    BASSOULLET, MT
    MARLARD, M
    SPENLEHAUER, G
    VEILLARD, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) : 493 - 498
  • [7] BODY DISTRIBUTION OF FULLY BIODEGRADABLE [C-14] POLY(LACTIC ACID) NANOPARTICLES COATED WITH ALBUMIN AFTER PARENTERAL ADMINISTRATION TO RATS
    BAZILE, DV
    ROPERT, C
    HUVE, P
    VERRECCHIA, T
    MARLARD, M
    FRYDMAN, A
    VEILLARD, M
    SPENLEHAUER, G
    [J]. BIOMATERIALS, 1992, 13 (15) : 1093 - 1102
  • [8] Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes
    Bettinger, T
    Remy, JS
    Erbacher, P
    [J]. BIOCONJUGATE CHEMISTRY, 1999, 10 (04) : 558 - 561
  • [9] Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
    Bhadriraju, K
    Hansen, LK
    [J]. BIOMATERIALS, 2000, 21 (03) : 267 - 272
  • [10] Intracellular route and transcriptional competence of polyethylenimine-DNA complexes
    Bieber, T
    Meissner, W
    Kostin, S
    Niemann, A
    Elsasser, HP
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 82 (2-3) : 441 - 454